TFX
Teleflex IncorporatedNYSEHealthcare$117.81-0.52%ClosedMarket Cap: $5.21B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.67
P/S
1.76
EV/EBITDA
68.44
DCF Value
$154.75
FCF Yield
4.7%
Div Yield
1.2%
Margins & Returns
Gross Margin
53.3%
Operating Margin
9.7%
Net Margin
-30.6%
ROE
-23.7%
ROA
-29.0%
ROIC
4.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $569.0M | 54.0% | $36.3M | $-714.3M | $-16.15 | $0.34 |
| FY 2025 | $1.99B | 56.2% | $255.8M | $-905.6M | $-20.25 | $1.36 |
| Q3 2025 | $913.0M | 49.5% | $-29.7M | $-408.9M | $-9.24 | $0.34 |
| Q2 2025 | $780.9M | 55.2% | $155.3M | $122.6M | $2.77 | $0.34 |
| Q1 2025 | $700.7M | 55.6% | $125.6M | $95.0M | $2.07 | $0.34 |
| Q4 2024 | $795.4M | 55.3% | $-110.4M | $-136.7M | $-2.95 | $0.34 |
| FY 2024 | $3.05B | 55.9% | $151.0M | $69.7M | $1.48 | $1.36 |
| Q3 2024 | $764.4M | 56.3% | $149.3M | $111.0M | $2.36 | $0.34 |
| Q2 2024 | $749.7M | 55.6% | $116.9M | $80.0M | $1.69 | $0.34 |
| Q1 2024 | $737.8M | 56.4% | $-4.8M | $15.3M | $0.32 | $0.34 |
| Q4 2023 | $773.9M | 55.7% | $82.5M | $31.1M | $0.66 | $0.34 |
| FY 2023 | $2.97B | 55.4% | $506.3M | $356.3M | $7.53 | $1.36 |